The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel ApproachLenka N.C. Boyd, Geert Kazemier, Laura L. Meijer et al.|Cancers|2022Cited by 41
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood BiomarkersLenka N.C. Boyd, Geert Kazemier, Mahsoem Ali et al.|JAMA Network Open|2023Cited by 17
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational studyLenka N.C. Boyd, Heinz‐Josef Klümpen, Lynn E. Nooijen et al.|Frontiers in Pharmacology|2023Cited by 10
Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer CellsPei Pei, Elisa Giovannetti, Alessandro Gregori et al.|International Journal of Radiation Oncology*Biology*Physics|2023Cited by 4